The Effects of Synaquell on Brain Function of Ice Hockey Players

Overview

About this study

The purpose of this study is to investigate the dietary supplement, Synaquell (TM), for effects on brain function.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • 18 years of age or greater.
  • Fluent English speakers.
  • Medically cleared to play ice hockey.

Exclusion Criteria:

  • An allergy to the ingredients of Synaquell or Synaquell+ (Magnesium, beta hydroxybutyrate, Glutathione, N-acetyl-L-cysteine, Riboflavin, Magnesium, Leucine,
  • Isoleucine, Valine, Resveratrol, Curcumin Phytosome, Nicotinamide riboside,
  • Docosahexanoic Acid).
  • Clinically documented hearing issues.
  • In-ear hearing aid or cochlear implant.
  • Implanted pacemaker or defibrillator.
  • Metal or plastic implants in skull.
  • Lack of verbal fluency in the English language.
  • History of seizures.
  • Allergy to rubbing alcohol or EEG gel.
  • Unhealthy scalp.

Eligibility last updated 4/11/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Mario Hevesi, M.D., Ph.D.

Closed for enrollment

Contact information:

Sydney Kalina

Kalina.Sydney@mayo.edu

More information

Publications

Publications are currently not available